Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders
Providing Access to Cord Blood Units for Transplants
Reduced Toxicity Conditioning Prior to Unrelated Cord Cell Transplantation for High Risk Myeloid Malignancies
Prophylactic Infusion of Donor Lymphocytes in Cord Blood Transplantation
† Study has passed its completion date and status has not been verified in more than two years.